표피 성장 인자 수용체 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "표피 성장 인자 수용체" in Korean language version.

refsWebsite

Global rank Korean rank

23nih.gov

4^th place

20doi.org

2^nd place

3^rd place

1harvard.edu

18^th place

27^th place

1web.archive.org

1^st place

1cshl.edu

low place

cshl.edu

repository.cshl.edu

“Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib” (PDF). 《The New England Journal of Medicine》 350 (21): 2129–39. May 2004. doi:10.1056/NEJMoa040938. PMID 15118073. 2018년 7월 21일에 원본 문서 (PDF)에서 보존된 문서. 2023년 10월 5일에 확인함.

doi.org

dx.doi.org

“Review of epidermal growth factor receptor biology”. 《International Journal of Radiation Oncology, Biology, Physics》 59 (2 Suppl): 21–6. 2004. doi:10.1016/j.ijrobp.2003.11.041. PMID 15142631.
“ErbB receptors: from oncogenes to targeted cancer treatment”. 《The Journal of Clinical Investigation》 117 (8): 2051–8. August 2007. doi:10.1172/JCI32278. PMC 1934579. PMID 17671639.
“Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor”. 《Biochemistry》 26 (5): 1443–51. March 1987. doi:10.1021/bi00379a035. PMID 3494473.
“Mechanisms of activation of receptor tyrosine kinases: monomers or dimers”. 《Cells》 3 (2): 304–30. April 2014. doi:10.3390/cells3020304. PMC 4092861. PMID 24758840.
“Nanoscale imaging of epidermal growth factor receptor clustering: effects of inhibitors”. 《The Journal of Biological Chemistry》 (영어) 285 (5): 3145–3156. January 2010. doi:10.1074/jbc.M109.073338. PMC 2823441. PMID 19959837.
“Autophosphorylation sites on the epidermal growth factor receptor”. 《Nature》 311 (5985): 483–5. 1984. Bibcode:1984Natur.311..483D. doi:10.1038/311483a0. PMID 6090945.
“A comprehensive pathway map of epidermal growth factor receptor signaling”. 《Molecular Systems Biology》 1 (1): E1–E17. 2005. doi:10.1038/msb4100014. PMC 1681468. PMID 16729045.
“Amphiregulin: role in mammary gland development and breast cancer”. 《Journal of Mammary Gland Biology and Neoplasia》 13 (2): 159–69. June 2008. doi:10.1007/s10911-008-9075-7. PMID 18398673.
“The ADAM17-amphiregulin-EGFR axis in mammary development and cancer”. 《Journal of Mammary Gland Biology and Neoplasia》 13 (2): 181–94. June 2008. doi:10.1007/s10911-008-9084-6. PMC 2723838. PMID 18470483.
“Effect of exogenous epidermal-like growth factors on mammary gland development and differentiation in the estrogen receptor-alpha knockout (ERKO) mouse”. 《Breast Cancer Research and Treatment》 79 (2): 161–73. May 2003. doi:10.1023/a:1023938510508. PMID 12825851.
“Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus”. 《Human Pathology》 40 (11): 1517–27. November 2009. doi:10.1016/j.humpath.2009.05.010. PMID 19716155.
“Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib” (PDF). 《The New England Journal of Medicine》 350 (21): 2129–39. May 2004. doi:10.1056/NEJMoa040938. PMID 15118073. 2018년 7월 21일에 원본 문서 (PDF)에서 보존된 문서. 2023년 10월 5일에 확인함.
“EGF mutant receptor vIII as a molecular target in cancer therapy”. 《Endocrine-Related Cancer》 8 (2): 83–96. June 2001. doi:10.1677/erc.0.0080083. PMID 11397666.
“Knockdown of EGFR inhibits growth and invasion of gastric cancer cells”. 《Cancer Gene Therapy》 21 (11): 491–7. November 2014. doi:10.1038/cgt.2014.55. PMID 25394504.
“The epidermal growth factor receptors and their family of ligands: their putative role in atherogenesis”. 《Atherosclerosis》 186 (1): 38–53. May 2006. doi:10.1016/j.atherosclerosis.2005.06.038. PMID 16076471.
“Epithelial inflammation resulting from an inherited loss-of-function mutation in EGFR”. 《The Journal of Investigative Dermatology》 134 (10): 2570–8. October 2014. doi:10.1038/jid.2014.164. PMC 4090136. PMID 24691054.
“MicroRNA-7 inhibition rescues age-associated loss of epidermal growth factor receptor and hyaluronan-dependent differentiation in fibroblasts”. 《Aging Cell》 13 (2): 235–44. April 2014. doi:10.1111/acel.12167. PMC 4331777. PMID 24134702.
“Osimertinib: First Global Approval”. 《Drugs》 76 (2): 263–273. February 2016. doi:10.1007/s40265-015-0533-4. PMID 26729184.
“Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nationwide registry study”. 《The Lancet Regional Health. Europe》 27: 100592. April 2023. doi:10.1016/j.lanepe.2023.100592. PMC 9932646. PMID 36817181.
“Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development”. 《BioTechniques》 39 (4): 565–8. October 2005. doi:10.2144/000112043. PMID 16235569.

harvard.edu

adsabs.harvard.edu

“Autophosphorylation sites on the epidermal growth factor receptor”. 《Nature》 311 (5985): 483–5. 1984. Bibcode:1984Natur.311..483D. doi:10.1038/311483a0. PMID 6090945.

nih.gov

ncbi.nlm.nih.gov

“Review of epidermal growth factor receptor biology”. 《International Journal of Radiation Oncology, Biology, Physics》 59 (2 Suppl): 21–6. 2004. doi:10.1016/j.ijrobp.2003.11.041. PMID 15142631.
“ErbB receptors: from oncogenes to targeted cancer treatment”. 《The Journal of Clinical Investigation》 117 (8): 2051–8. August 2007. doi:10.1172/JCI32278. PMC 1934579. PMID 17671639.
“Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor”. 《Biochemistry》 26 (5): 1443–51. March 1987. doi:10.1021/bi00379a035. PMID 3494473.
“Mechanisms of activation of receptor tyrosine kinases: monomers or dimers”. 《Cells》 3 (2): 304–30. April 2014. doi:10.3390/cells3020304. PMC 4092861. PMID 24758840.
“Nanoscale imaging of epidermal growth factor receptor clustering: effects of inhibitors”. 《The Journal of Biological Chemistry》 (영어) 285 (5): 3145–3156. January 2010. doi:10.1074/jbc.M109.073338. PMC 2823441. PMID 19959837.
“Autophosphorylation sites on the epidermal growth factor receptor”. 《Nature》 311 (5985): 483–5. 1984. Bibcode:1984Natur.311..483D. doi:10.1038/311483a0. PMID 6090945.
“A comprehensive pathway map of epidermal growth factor receptor signaling”. 《Molecular Systems Biology》 1 (1): E1–E17. 2005. doi:10.1038/msb4100014. PMC 1681468. PMID 16729045.
“Activation and function of the epidermal growth factor receptor and erbB-2 during mammary gland morphogenesis”. 《Cell Growth & Differentiation》 9 (9): 777–85. September 1998. PMID 9751121.
“Amphiregulin: role in mammary gland development and breast cancer”. 《Journal of Mammary Gland Biology and Neoplasia》 13 (2): 159–69. June 2008. doi:10.1007/s10911-008-9075-7. PMID 18398673.
“The ADAM17-amphiregulin-EGFR axis in mammary development and cancer”. 《Journal of Mammary Gland Biology and Neoplasia》 13 (2): 181–94. June 2008. doi:10.1007/s10911-008-9084-6. PMC 2723838. PMID 18470483.
“Effect of exogenous epidermal-like growth factors on mammary gland development and differentiation in the estrogen receptor-alpha knockout (ERKO) mouse”. 《Breast Cancer Research and Treatment》 79 (2): 161–73. May 2003. doi:10.1023/a:1023938510508. PMID 12825851.
“Induction of ductal morphogenesis and lobular hyperplasia by amphiregulin in the mouse mammary gland”. 《Cell Growth & Differentiation》 7 (12): 1769–81. December 1996. PMID 8959346.
“Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus”. 《Human Pathology》 40 (11): 1517–27. November 2009. doi:10.1016/j.humpath.2009.05.010. PMID 19716155.
“Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib” (PDF). 《The New England Journal of Medicine》 350 (21): 2129–39. May 2004. doi:10.1056/NEJMoa040938. PMID 15118073. 2018년 7월 21일에 원본 문서 (PDF)에서 보존된 문서. 2023년 10월 5일에 확인함.
“EGF mutant receptor vIII as a molecular target in cancer therapy”. 《Endocrine-Related Cancer》 8 (2): 83–96. June 2001. doi:10.1677/erc.0.0080083. PMID 11397666.
“Knockdown of EGFR inhibits growth and invasion of gastric cancer cells”. 《Cancer Gene Therapy》 21 (11): 491–7. November 2014. doi:10.1038/cgt.2014.55. PMID 25394504.
“The EGF receptor – an essential regulator of multiple epidermal functions”. 《European Journal of Dermatology》 10 (7): 505–10. 2000. PMID 11056418.
“The epidermal growth factor receptors and their family of ligands: their putative role in atherogenesis”. 《Atherosclerosis》 186 (1): 38–53. May 2006. doi:10.1016/j.atherosclerosis.2005.06.038. PMID 16076471.
“Epithelial inflammation resulting from an inherited loss-of-function mutation in EGFR”. 《The Journal of Investigative Dermatology》 134 (10): 2570–8. October 2014. doi:10.1038/jid.2014.164. PMC 4090136. PMID 24691054.
“MicroRNA-7 inhibition rescues age-associated loss of epidermal growth factor receptor and hyaluronan-dependent differentiation in fibroblasts”. 《Aging Cell》 13 (2): 235–44. April 2014. doi:10.1111/acel.12167. PMC 4331777. PMID 24134702.
“Osimertinib: First Global Approval”. 《Drugs》 76 (2): 263–273. February 2016. doi:10.1007/s40265-015-0533-4. PMID 26729184.
“Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nationwide registry study”. 《The Lancet Regional Health. Europe》 27: 100592. April 2023. doi:10.1016/j.lanepe.2023.100592. PMC 9932646. PMID 36817181.
“Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development”. 《BioTechniques》 39 (4): 565–8. October 2005. doi:10.2144/000112043. PMID 16235569.

web.archive.org

“Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib” (PDF). 《The New England Journal of Medicine》 350 (21): 2129–39. May 2004. doi:10.1056/NEJMoa040938. PMID 15118073. 2018년 7월 21일에 원본 문서 (PDF)에서 보존된 문서. 2023년 10월 5일에 확인함.